CD19 and lymphoma: Furthermore, the infusion of CD70 CAR NK cells into mice inoculated with lymphoma cells demonstrated that CAR NK cells targeting CD70 exhibited not only effectiveness against CD19+ tumor cells but also a certain degree of efficacy against CD19- tumor cells, thereby demonstrating superior efficacy in comparison to CAR NK cells targeting CD19.